Annual Cost Of Goods Sold
$94.94 M
+$52.76 M+125.07%
31 December 2022
Summary:
Eagle Pharmaceuticals annual cost of goods sold is currently $94.94 million, with the most recent change of +$52.76 million (+125.07%) on 31 December 2022. During the last 3 years, it has risen by +$49.47 million (+108.81%). EGRX annual cost of goods sold is now at all-time high.EGRX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$16.86 M
-$442.00 K-2.55%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly cost of goods sold is currently $16.86 million, with the most recent change of -$442.00 thousand (-2.55%) on 30 June 2023. EGRX quarterly cost of goods sold is now -39.26% below its all-time high of $27.75 million, reached on 31 March 2022.EGRX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$77.67 M
-$6.81 M-8.06%
30 June 2023
Summary:
Eagle Pharmaceuticals TTM cost of goods sold is currently $77.67 million, with the most recent change of -$6.81 million (-8.06%) on 30 June 2023. EGRX TTM cost of goods sold is now -18.18% below its all-time high of $94.94 million, reached on 31 December 2022.EGRX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +108.8% | +104.1% | +83.1% |
| 5 y5 years | +53.3% | +13.0% | +14.5% |
EGRX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +125.1% | -39.3% | +104.1% | -18.2% | +84.2% |
| 5 y | 5 years | at high | +125.1% | -39.3% | +116.0% | -18.2% | +84.2% |
| alltime | all time | at high | +2898.6% | -39.3% | +7882.0% | -18.2% | >+9999.0% |
Eagle Pharmaceuticals Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $16.86 M(-2.6%) | $77.67 M(-8.1%) |
| Mar 2023 | - | $17.30 M(-12.9%) | $84.48 M(-11.0%) |
| Dec 2022 | $94.94 M(+125.1%) | $19.87 M(-16.0%) | $94.94 M(+8.6%) |
| Sept 2022 | - | $23.65 M(-0.1%) | $87.38 M(+21.4%) |
| June 2022 | - | $23.66 M(-14.7%) | $71.99 M(+21.8%) |
| Mar 2022 | - | $27.75 M(+125.5%) | $59.08 M(+40.1%) |
| Dec 2021 | $42.18 M(-7.2%) | $12.31 M(+49.0%) | $42.18 M(-0.5%) |
| Sept 2021 | - | $8.26 M(-23.2%) | $42.41 M(-8.1%) |
| June 2021 | - | $10.76 M(-0.9%) | $46.14 M(-4.9%) |
| Mar 2021 | - | $10.86 M(-13.4%) | $48.52 M(+6.7%) |
| Dec 2020 | $45.47 M(-25.3%) | $12.54 M(+4.6%) | $45.47 M(+2.1%) |
| Sept 2020 | - | $11.99 M(-8.7%) | $44.52 M(-6.2%) |
| June 2020 | - | $13.13 M(+68.3%) | $47.45 M(-14.7%) |
| Mar 2020 | - | $7.80 M(-32.7%) | $55.60 M(-8.7%) |
| Dec 2019 | $60.90 M(-1.6%) | $11.59 M(-22.3%) | $60.90 M(-10.3%) |
| Sept 2019 | - | $14.92 M(-29.9%) | $67.86 M(+2.9%) |
| June 2019 | - | $21.28 M(+62.5%) | $65.93 M(+4.3%) |
| Mar 2019 | - | $13.10 M(-29.4%) | $63.21 M(+2.1%) |
| Dec 2018 | $61.92 M(+8.3%) | $18.56 M(+42.8%) | $61.91 M(+8.5%) |
| Sept 2018 | - | $12.99 M(-30.0%) | $57.06 M(+2.4%) |
| June 2018 | - | $18.56 M(+57.2%) | $55.74 M(+9.3%) |
| Mar 2018 | - | $11.81 M(-13.8%) | $51.00 M(-10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $57.19 M(+3.4%) | $13.71 M(+17.5%) | $57.19 M(-8.2%) |
| Sept 2017 | - | $11.66 M(-15.6%) | $62.30 M(+2.0%) |
| June 2017 | - | $13.82 M(-23.2%) | $61.06 M(+4.0%) |
| Mar 2017 | - | $17.99 M(-4.4%) | $58.71 M(+6.2%) |
| Dec 2016 | $55.31 M(+253.5%) | $18.82 M(+80.5%) | $55.31 M(+41.5%) |
| Sept 2016 | - | $10.43 M(-9.1%) | $39.09 M(+20.6%) |
| June 2016 | - | $11.47 M(-21.4%) | $32.41 M(+33.5%) |
| Mar 2016 | - | $14.59 M(+461.5%) | $24.29 M(+55.2%) |
| Dec 2015 | $15.65 M(+33.6%) | $2.60 M(-30.8%) | $15.65 M(-10.8%) |
| Sept 2015 | - | $3.75 M(+12.1%) | $17.54 M(+9.9%) |
| June 2015 | - | $3.35 M(-43.7%) | $15.96 M(+12.7%) |
| Mar 2015 | - | $5.95 M(+32.5%) | $14.17 M(+22.4%) |
| Dec 2014 | - | $4.49 M(+106.4%) | $11.58 M(-1.2%) |
| Sept 2014 | $11.71 M(+58.7%) | $2.17 M(+39.8%) | $11.71 M(-6.1%) |
| June 2014 | - | $1.56 M(-53.7%) | $12.47 M(-9.9%) |
| Mar 2014 | - | $3.36 M(-27.3%) | $13.84 M(+17.4%) |
| Dec 2013 | - | $4.62 M(+57.7%) | $11.79 M(+59.8%) |
| Sept 2013 | $7.38 M(+133.1%) | $2.93 M(+0.2%) | $7.38 M(+65.9%) |
| June 2013 | - | $2.92 M(+122.8%) | $4.45 M(+191.9%) |
| Mar 2013 | - | $1.31 M(+521.7%) | $1.52 M(+621.7%) |
| Dec 2012 | - | $211.20 K | $211.20 K |
| Sept 2012 | $3.17 M | - | - |
FAQ
- What is Eagle Pharmaceuticals annual cost of goods sold?
- What is the all time high annual cost of goods sold for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual cost of goods sold?
The current annual cost of goods sold of EGRX is $94.94 M
What is the all time high annual cost of goods sold for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual cost of goods sold is $94.94 M
What is Eagle Pharmaceuticals quarterly cost of goods sold?
The current quarterly cost of goods sold of EGRX is $16.86 M
What is the all time high quarterly cost of goods sold for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly cost of goods sold is $27.75 M
What is Eagle Pharmaceuticals TTM cost of goods sold?
The current TTM cost of goods sold of EGRX is $77.67 M
What is the all time high TTM cost of goods sold for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM cost of goods sold is $94.94 M